ARSA mRNA expression tended to increase with NAFL and was strongly upregulated with NASH (Fig. 2a), effects that were related to steatosis and hepatocyte ballooning, but not inflammation or fibrosis (Supplementary Fig. S2A–D). This evidence concerns the gene ARSA and metabolic dysfunction-associated steatohepatitis.